Neoleukin Therapeutics In... (NLTX)

AI Score

Unlock

3.49

0.05 (1.45%)

At close: Dec 18, 2023, 9:00 PM

Neoleukin Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
PE Ratio	-9.69	-22.36	-1.93	-2.23	-2.82	-3.71	-6.75	-17.51	-25.79	-33.57	-45.24	-57.81	-288.78	-84.13	-64.75	-41.11	-1.26	-54.84K	-29.1	-10.4	-4.49	21.36	-22.61	-16.97	-28.14	-23.96	-47.01	-34.39	-29.01	-10.45	-22.62
PEG Ratio	-0.08	0.25	-0.00	0.03	-0.01	n/a	n/a	n/a	-6.96	n/a	-2.6	-0.13	3.65	-7.57	-5.18	0.44	n/a	548.42	0.53	0.15	0.01	-0.18	2.23	-0.45	1.84	-0.38	1.88	-7.91	1.08	-0.17	-1.24
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	177.08K	265.52K	n/a	n/a	6.48K	2.6M	n/a	n/a	n/a	n/a	n/a	n/a	-8.13	n/a	9.97	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	2.33	2.34	1.91	1.19	1.34	1.95	3.19	7.44	10.29	12.16	15.12	15.29	12.97	25.48	16.32	9.40	4.46	3.03	3.59	2.80	3.51	2.75	15.41	11.16	11.67	10.59	11.42	10.69	6.08	4.95	5.93
P/FCF Ratio	-41.09	-44.59	-11.54	-10.2	-14.72	-19.73	-28.51	-84.56	-170.52	-140.43	-187.27	-295.78	-4.34K	-335.82	-341.86	-245.86	-45.03	-149.23	-93.26	-20.8	-17.51	27.24	-84.61	-95	-115.25	-123.93	-137.31	-170.1	-122.19	-55.52	-102.94
P/OCF Ratio	-41.09	-46.05	-11.91	-10.3	-15.23	-20.14	-29.43	-87.32	-181.95	-153.03	-202.54	-316.71	-23.2K	-372.94	-347.54	-287.33	-45.7	-149.23	-93.26	-20.8	-17.49	27.16	-84.83	-95.13	-115.51	-128.06	-138.63	-171.93	-127.05	-57.58	-103.41
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.03K	-1.46K	n/a	n/a	-20.46	-112	n/a	n/a	n/a	n/a	n/a	n/a	0.39	n/a	0.37	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.14	0.14	0.14	0.13	0.11	0.11	0.10	0.09	0.09	0.08	0.08	0.06	0.06	0.08	0.08	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Quick Ratio	15.33	17.17	11.97	8.96	10.63	12.78	17.16	16.67	17.40	22.09	21.57	24.66	20.88	20.73	24.92	30.28	26.35	63.17	20.81	16.68	8.12	7.73	10.07	9.93	17.23	16.26	21.02	10.87	17.12	7.96	12.14
Current Ratio	15.33	17.17	11.97	8.96	10.63	12.78	17.16	16.67	17.40	22.09	21.57	24.66	20.88	20.73	24.92	30.28	26.35	63.17	20.81	16.68	8.12	7.73	10.07	9.93	17.23	16.26	21.02	10.87	17.12	7.96	12.14
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	0.00	n/a	n/a	0.00	0.00	n/a	n/a	n/a	n/a	n/a	n/a	-0.32	n/a	0.24	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	16.26	-17.46	-24.35	-81.81	-1.18K	-3.03K	-2.57K	-3.03K	-4.98K	-18.27K	321.43	-207.36	-19.91	8.36K	n/a	n/a	n/a	1.32K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.46K	n/a	n/a	n/a
Return on Equity	-0.06	-0.03	-0.25	-0.13	-0.12	-0.13	-0.12	-0.11	-0.1	-0.09	-0.08	-0.07	-0.01	-0.08	-0.06	-0.06	-0.88	n/a	-0.03	-0.07	-0.2	0.03	-0.17	-0.16	-0.1	-0.11	-0.06	-0.08	-0.05	-0.12	-0.07
Return on Assets	-0.05	-0.02	-0.2	-0.11	-0.1	-0.11	-0.1	-0.09	-0.09	-0.08	-0.07	-0.06	-0.01	-0.07	-0.06	-0.06	-0.85	n/a	-0.03	-0.06	-0.17	0.03	-0.15	-0.15	-0.1	-0.1	-0.06	-0.07	-0.05	-0.11	-0.06
Return on Invested Capital	-0.06	-0.03	-0.23	-0.13	-0.11	-0.12	-0.11	-0.1	-0.09	-0.08	-0.08	-0.27	0.01	-0.07	-0.06	-0.06	-0.88	2.51	-0.03	-0.07	-0.2	0.03	-0.17	-0.16	-0.1	-0.11	-0.06	-0.08	-0.05	-0.12	-0.07
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.05	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.26	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	1.00	n/a	n/a	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.53K	-2.57K	n/a	n/a	-28.03	-2.25K	n/a	n/a	n/a	n/a	n/a	n/a	0.20	n/a	0.12	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.53K	-2.57K	n/a	n/a	-28.03	-2.25K	n/a	n/a	n/a	n/a	n/a	n/a	0.20	n/a	0.12	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.53K	-2.57K	n/a	n/a	-121.55	2.25K	n/a	n/a	n/a	n/a	n/a	n/a	0.21	n/a	0.11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.42K	-2.48K	n/a	n/a	-27	-17.46K	n/a	n/a	n/a	n/a	n/a	n/a	0.17	n/a	0.11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a